Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jan. 31, 2026	Jan. 31, 2025
Cash flows from operating activities:
Net income	$ 661	$ 723
Adjustments to reconcile net income to net cash provided by operations:
Equity method investment income and gain on sale	0	(83)
Depreciation and amortization	68	66
Stock-based compensation expense	22	20
Deferred income tax benefit	(29)	(43)
Change in fair value of contingent consideration	(1)	5
Other, net	(3)	(3)
Changes in assets and liabilities:
Accounts receivable	(126)	(106)
Inventories	(24)	(61)
Other current assets	(17)	21
Accounts payable and accrued expenses	77	(64)
Accrued income taxes	15	(10)
Other operating assets and liabilities	66	(19)
Cash provided by operating activities	709	446
Cash flows from investing activities:
Proceeds from sale of equity method investment	0	350
Additions to property, plant, and equipment	(81)	(117)
Proceeds from sale of cooperage assets	33	51
Cash provided by (used for) investing activities	(48)	284
Cash flows from financing activities:
Net change in short term borrowings	(13)	(227)
Payments of withholding taxes related to stock-based awards	(1)	(2)
Acquisition of treasury stock	(400)	0
Dividends paid	(321)	(313)
Other, net	(2)	(4)
Cash used for financing activities	(737)	(546)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	15	(20)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(61)	164
Cash, cash equivalents, and restricted cash at beginning of period	463	456
Cash, cash equivalents, and restricted cash at end of period	402	620
Less: Restricted cash (included in other current assets) at end of period	(19)	(21)
Cash and cash equivalents at end of period	383	599
Supplemental information:
Non-cash additions to property, plant and equipment	2	7
Right-of-use assets obtained in exchange for new lease obligations	$ 22	$ 30